Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy (CardioMET)

Federico II University

Status: Enrolling

Conditions: Type 2 Diabetes

Treatments: Other: data collection

Study type: Observational

Funder types: Other

Identifiers

NCT07375069

Prot. 189/2022

Details and patient eligibility

About

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years;
• Diagnosis of type 2 diabetes mellitus (T2DM);
• Ability to understand the study procedures and provide written informed consent.

Exclusion criteria

• Known or suspected liver disease;
• Patients with type 1 diabetes mellitus;
• Cardiac surgery or percutaneous coronary revascularization scheduled within the next 3 months;
• Patients with acute inflammatory or infectious diseases during the previous 3 months;
• Patients with chronic inflammatory, immune, or infectious diseases;
• Patients with ongoing malignant neoplasms;
• History of alcohol, drug, or medication abuse;
• Clinically significant hematological disorders;
• Systemic steroid treatment within the last 6 months;
• Acute-phase metabolic disorders;
• Any condition that may put the patient at risk by participating in the study.